(Q70976547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Levonantradol for chemotherapy-induced emesis: phase I-II oral administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral Administration (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

21 April 2024

1 reference

J. Laszlo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7298875

21 April 2024

V. S. Lucas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7298875

21 April 2024

D. C. Hanson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7298875

21 April 2024

C. M. Cronin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7298875

21 April 2024

S. E. Sallan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7298875

21 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7298875

21 April 2024

publication date

1 August 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

15 October 2019

http://www.jclinpharm.org/cgi/content/abstract/21/8-9/51S

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7298875

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1981.tb02573.x

21 April 2024

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1002/j.1552-4604.1981.tb02573.x

21 April 2024

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

The Journal of Clinical Pharmacology

21 April 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

51S-56S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

S1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

Cancer Treatment Needs Better Antiemetics

15 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

21 April 2024

3

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

21 April 2024

5

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

21 April 2024

6

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Tetrahydrocannabinol: From Pot to Prescription?

21 April 2024

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo

21 April 2024

9

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy

21 April 2024

10

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy

21 April 2024

13

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1981.TB02573.X

21 April 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7298875%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference